Cardiovascular Systems Inc. (CSII)

44.32
NASDAQ : Health Technology
Prev Close 44.48
Day Low/High 44.01 / 44.88
52 Wk Low/High 24.84 / 46.52
Avg Volume 278.20K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.55B
EPS 0.10
P/E Ratio 741.33
Div & Yield N.A. (N.A)

Cardiovascular Systems To Webcast Fiscal 2010 Fourth-Quarter And Full-Year Earnings Conference Call Tuesday, August 10

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2010 fourth-quarter and full-year conference call on Tuesday, August 10, 2010, at 3:45 p.

Cardiovascular Systems Launches Diamondback Predator 360°™ PAD System

Cardiovascular Systems Launches Diamondback Predator 360°™ PAD System

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has launched its second-generation product, the Diamondback Predator 360°™ PAD System, for the treatment of peripheral arterial disease (PAD).

Cardiovascular Systems Enrolls First Patient In ORBIT II Coronary Clinical Trial

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announces the first patient enrollment in its ORBIT II Investigational Device Exemption (IDE) clinical trial to evaluate the safety and effectiveness of its ...

Cardiovascular Systems Completes Patient Enrollment In COMPLIANCE 360° Clinical Trial

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has completed patient enrollment in its COMPLIANCE 360° clinical trial, part of the company’s 360° Clinical Series.

Cardiovascular Systems To Present At The 2010 Citi Investment Research Global Health Care Conference

Cardiovascular Systems, Inc. (Nasdaq: CSII) will present at the 2010 Citi Investment Research Global Health Care Conference at the New York Hilton, New York City.

Cardiovascular Systems Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript

Cardiovascular Systems Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript

Cardiovascular Systems Reports Fiscal Third-Quarter 2010 Financial Results

Cardiovascular Systems Reports Fiscal Third-Quarter 2010 Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Key financial results improved in fiscal third quarter 2010 over prior-year quarter Revenue increased 9 percent to $16.

Cardiovascular Systems Completes Enrollment In CALCIUM 360° Clinical Trial

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has completed patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series.

Cardiovascular Systems To Webcast Fiscal 2010 Third-Quarter Earnings Conference Call Wednesday, May 5

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2010 third-quarter conference call on Wednesday, May 5, 2010, at 3:45 p.

Sirius XM, Conexant Systems: Early Volume Plays

Sirius XM was among several stocks trading near $5 poised to move on above-average volume during Wednesday's session.

Cardiovascular Systems Receives Unconditional FDA Approval For ORBIT II Coronary Clinical Trial

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial ...

Cardiovascular Systems Completes $29 Million Debt Facility With Silicon Valley Bank And Partners For Growth

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announced today that it has established a $25 million credit facility with Silicon Valley Bank and up to $4 million in convertible debt with Partners for Growth.

CEO Buys $1.1M Worth of Prospect Capital

CEO Buys $1.1M Worth of Prospect Capital

Prospect Capital CEO John Barry buys 100,000 shares.

Cardiovascular Systems To Webcast Fiscal 2010 Second-Quarter Earnings Conference Call Wednesday, February 3

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2010 second-quarter conference call on Wednesday, February 3, 2010, at 3:45 p.

TheStreet Quant Rating: C (Hold)